Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$2.85 - $7.77 $117,898 - $321,429
-41,368 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$5.7 - $9.3 $56,167 - $91,642
9,854 Added 31.27%
41,368 $314,000
Q4 2021

Feb 14, 2022

SELL
$8.73 - $15.27 $272,541 - $476,714
-31,219 Reduced 49.76%
31,514 $275,000
Q3 2021

Nov 12, 2021

SELL
$13.52 - $23.95 $132,212 - $234,207
-9,779 Reduced 13.49%
62,733 $869,000
Q2 2021

Aug 13, 2021

BUY
$22.12 - $32.06 $7,631 - $11,060
345 Added 0.48%
72,512 $1.76 Million
Q1 2021

May 14, 2021

BUY
$26.12 - $52.17 $1.02 Million - $2.04 Million
39,186 Added 118.81%
72,167 $2.32 Million
Q4 2020

Feb 12, 2021

BUY
$14.05 - $29.0 $463,383 - $956,449
32,981 New
32,981 $811,000

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $1.81B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.